Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive breast cancer: A multidisciplinary approach

Barbara DuMond,Vidhi Patel,Anne Gross,Anita Fung,Susan Weber

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive breast cancer: A multidisciplinary approach

2021

Barbara DuMond
Vidhi Patel
Anne Gross
Anita Fung
Susan Weber

Pertuzumab plus trastuzumab, administered intravenously (IV) with chemotherapy, is standard treatment for HER2-positive metastatic or high-risk early breast cancer. Pertuzumab and trastuzumab are a...

Keywords:

Oncology
Standard treatment
Subcutaneous injection
Pertuzumab
Fixed-dose combination
HER2 Positive Breast Cancer
in patient
Medicine
Trastuzumab
Internal medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations